Literature DB >> 24717624

Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial.

Ganesh Raghu1, David Lynch2, J David Godwin3, Richard Webb4, Thomas V Colby5, Kevin O Leslie5, Juergen Behr6, Kevin K Brown2, James J Egan7, Kevin R Flaherty8, Fernando J Martinez8, Athol U Wells9, Lixin Shao10, Huafeng Zhou10, Patricia S Pedersen10, Rohit Sood11, A Bruce Montgomery12, Thomas G O'Riordan10.   

Abstract

BACKGROUND: Present guidelines for the diagnosis of idiopathic pulmonary fibrosis require histological confirmation of surgical lung biopsy samples when high-resolution CT images are not definitive for usual interstitial pneumonia. We aimed to assess the predictive value of high-resolution CT in a cohort of patients with suspected idiopathic pulmonary fibrosis from a previous randomised trial.
METHODS: ARTEMIS-IPF was a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial of ambrisentan for adults aged 40-80 years with well-defined idiopathic pulmonary fibrosis and 5% or less honeycombing on high-resolution CT. In December, 2010, an interim analysis showed lack of efficacy and the trial was stopped. In the present follow-on analysis, we assessed patients who were screened for ARTEMIS-IPF who underwent high-resolution CT as part of screening and surgical lung biopsy as part of standard clinical care. A radiologist and a pathologist from a central panel independently assessed anonymised CT scans and biopsy samples. We calculated the positive and negative predictive value of high-resolution CT (classified as usual interstitial pneumonia, possible usual interstitial pneumonia, and inconsistent with usual interstitial pneumonia) for confirmation of histological patterns of usual interstitial pneumonia. This study is registered with ClinicalTrials.gov, number NCT00768300.
FINDINGS: 315 (29%) of 1087 consecutively screened patients in ARTEMIS-IPF had both high-resolution CT and surgical lung biopsy samples. 108 of 111 patients who met high-resolution CT criteria for usual interstitial pneumonia had histologically confirmed usual interstitial pneumonia (positive predictive value 97·3%, 95% CI 92·3-99·4), as did 79 of 84 patients who met high-resolution CT criteria for possible usual interstitial pneumonia (94·0%, 86·7-98·0). 22 of 120 patients had an inconsistent high-resolution CT pattern for usual interstitial pneumonia that was histologically confirmed as not or possible usual interstitial pneumonia (negative predictive value 18·3%, 95% CI 11·9-26·4).
INTERPRETATION: In the appropriate clinical setting, for patients with possible usual interstitial pneumonia pattern on high resolution CT, surgical lung biopsy sampling might not be necessary to reach a diagnosis of idiopathic pulmonary fibrosis if high-resolution CT scans are assessed by experts at regional sites familiar with patterns of usual interstitial pneumonia and management of idiopathic interstitial pneumonia. FUNDING: Gilead Sciences.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24717624     DOI: 10.1016/S2213-2600(14)70011-6

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  48 in total

1.  The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.

Authors:  Robert Brownell; Teng Moua; Travis S Henry; Brett M Elicker; Darin White; Eric Vittinghoff; Kirk D Jones; Anatoly Urisman; Carlos Aravena; Kerri A Johannson; Jeffrey A Golden; Talmadge E King; Paul J Wolters; Harold R Collard; Brett Ley
Journal:  Thorax       Date:  2017-01-12       Impact factor: 9.139

2.  Characterisation of patients with interstitial pneumonia with autoimmune features.

Authors:  Justin M Oldham; Ayodeji Adegunsoye; Eleanor Valenzi; Cathryn Lee; Leah Witt; Lena Chen; Aliya N Husain; Steven Montner; Jonathan H Chung; Vincent Cottin; Aryeh Fischer; Imre Noth; Rekha Vij; Mary E Strek
Journal:  Eur Respir J       Date:  2016-04-21       Impact factor: 16.671

3.  Volume-related structures predict UIP pathology in those with a non-IPF pattern on CT.

Authors:  Jonathan H Chung; Ayodeji Adegunsoye; Justin M Oldham; Rekha Vij; Aliya Husain; Steven M Montner; Ronald A Karwoski; Brian J Bartholmai; Mary E Strek
Journal:  Eur Radiol       Date:  2021-04-13       Impact factor: 5.315

4.  What Is in a Pattern? That Which We Call Idiopathic Pulmonary Fibrosis by Any Other Pattern Would Behave Alike!

Authors:  Joao A de Andrade; Tracy Luckhardt
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

5.  Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT.

Authors:  Lisa P Lavelle; Darragh Brady; Sinead McEvoy; David Murphy; Brian Gibney; Annika Gallagher; Marcus Butler; Fionnula Shortt; Marie McMullen; Aurelie Fabre; David A Lynch; Michael P Keane; Jonathan D Dodd
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

6.  Idiopathic interstitial pneumonias: do HRCT criteria established by ATS/ERS/JRS/ALAT in 2011 predict disease progression and prognosis?

Authors:  Chiara Romei; Laura Tavanti; Paola Sbragia; Annalisa De Liperi; Laura Carrozzi; Ferruccio Aquilini; Antonio Palla; Fabio Falaschi
Journal:  Radiol Med       Date:  2015-03-06       Impact factor: 3.469

7.  Automated classification of usual interstitial pneumonia using regional volumetric texture analysis in high-resolution computed tomography.

Authors:  Adrien Depeursinge; Anne S Chin; Ann N Leung; Donato Terrone; Michael Bristow; Glenn Rosen; Daniel L Rubin
Journal:  Invest Radiol       Date:  2015-04       Impact factor: 6.016

8.  Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.

Authors:  Margaret L Salisbury; Meng Xia; Susan Murray; Brian J Bartholmai; Ella A Kazerooni; Catherine A Meldrum; Fernando J Martinez; Kevin R Flaherty
Journal:  Respir Med       Date:  2016-07-28       Impact factor: 3.415

9.  MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.

Authors:  Harinath Bahudhanapati; Jiangning Tan; Justin A Dutta; Stephen B Strock; John Sembrat; Diana Àlvarez; Mauricio Rojas; Benedikt Jäger; Antje Prasse; Yingze Zhang; Daniel J Kass
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

10.  Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.

Authors:  Eric S White; Meng Xia; Susan Murray; Rachel Dyal; Candace M Flaherty; Kevin R Flaherty; Bethany B Moore; Ling Cheng; Tracy J Doyle; Julian Villalba; Paul F Dellaripa; Ivan O Rosas; Jonathan D Kurtis; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.